NEKTAR THERAPEUTICS — Director's Dealing 2019

Oct 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2019-10-15

Reporting Person: Labrucherie Gil M (SVP, COO & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-15	Common Stock	M	25000	$7.21	Acquired	252872	Direct
2019-10-15	Common Stock	S	25000	$15.83	Disposed	227872	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-15	Stock Option	$7.21	M	25000	Disposed	2020-02-07	Common Stock (25000)	Direct

Footnotes

F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020.

F2: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).